What You Should Know
Greatly Health raised a $4 million seed round co-led by Pear VC and Commonweal Ventures to bring integrative oncology to a broader patient population.The company's virtual model was originally developed and validated at Memorial Sloan Kettering Cancer Center (MSK).In clinical trials, the program demonstrated a 16% absolute improvement in overall survival at two years and a 69% reduction in hospitalizations.The platform provides live, expert-led group sessions in exercise,
Read More
Oncology Platform
CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring
What You Should Know
CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cancers.The deal includes $160M in up-front cash, with potential for an additional $100M based on future revenue milestones.Naveris’ flagship platform utilizes Tumor Tissue Modified Viral (TTMV®) DNA to detect and monitor HPV-driven cancers with high accuracy.The acquisition is expected to close in the third quarter of
Read More
Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
What You Should Know
The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment.The Technology: Sonire has developed a proprietary High-Intensity Focused Ultrasound (HIFU) therapy system for the non-invasive thermal ablation of solid tumors.The Clinical Target: The company is initially focusing on
Read More
Mayo Clinic Platform Standardizes Cancer Data to Speed Up Trials
Mayo Clinic Platform Standardizes Cancer Data to Speed Up Trials
What You Should Know
The Upgrade: Mayo Clinic Platform_Orchestrate has launched new capabilities that allow researchers to access standardized, "research-ready" cancer data.The Standard: The platform now utilizes the OMOP Oncology framework, which structures complex, messy data (like pathology reports and tumor staging) into a consistent format that algorithms can easily analyze.The Future: Later this year, Mayo will
Read More
SimonMed Launches Ultrasound+ AI Program for Enhanced Breast and Thyroid Cancer Detection
What You Should Know:
- SimonMed Imaging, one of the largest outpatient medical imaging providers and radiology practices in the United States, today announced the launch of Ultrasound+, an AI-enabled ultrasound program.
- The program is powered by the FDA-cleared software, Koios DS, and is designed to assist with breast and thyroid cancer detection.
Embedding AI for Earlier and More Accurate Detection
Ultrasound+ represents a significant step in making advanced imaging
Read More
Daymark Health Secures $20M to Scale Value-Based Cancer Care
What You Should Know:
- Daymark Health, a company dedicated to redefining the cancer care experience secures $20M in Series A funding round led by Healthier Capital and Blue Venture Fund, with continued participation from existing investors including Yosemite, Maverick Ventures, and Oncology Ventures.
- The investment will allow Daymark Health to continue scaling its cancer care platform, forge new partnerships with health plans and providers, and bring its innovative technology to
Read More
MedStar Health Pilots On-Demand Cancer Care with Reimagine Care
What You Should Know:
- Reimagine Care, the nation’s leading provider of on-demand cancer care, today announced a pilot collaboration with MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region.
- MedStar Health will integrate Reimagine Care’s innovative on-demand oncology care platform into its cancer care delivery model, offering patients a seamless extension from their in-clinic care plan into the home.
Extending High-Quality Cancer Care
Read More
Flatiron Health, NRG Oncology to Streamline Cancer Clinical Trials with EHR-to-EDC
What You Should Know:
- Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute's (NCI) National Clinical Trials Network (NCTN).
- The partnership aims to deploy Flatiron’s Clinical Pipe™ in a multicenter NRG clinical trial, streamlining data entry and accelerating study timelines.
Supporting
Read More
Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities
What You Should Know:
- Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
- The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients.
AI-Powered Lung Nodule Analysis
Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More
C the Signs Raises $8M to Expand AI-Powered Cancer Detection to the U.S.
What You Should Know:
- C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
- The investment will fuel the company's expansion from the United Kingdom, where it has already achieved significant success in early cancer detection, to the United States.
Cancer Screening and Improve Patient Outcomes
C the Signs addresses a critical gap in cancer care by identifying patients at risk of cancer at
Read More
